Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1979-08-08
1981-07-14
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544 22, 544 25, 544 27, 544 28, A61K 31545, C07D50146
Patent
active
042786711
ABSTRACT:
A 7-[2-(2-aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido] cephalosporin derivative of the formula; ##STR1## wherein R.sub.3 is hydrogen or a residue of a nucleophilic compound; R.sub.2 NH is an amino group which may optionally be protected, pharmaceutically acceptable salt or ester thereof, is found to have excellent anti-bacterial activity against a broad spectrum of bacteria inclusive of gram-negative bacteria such as Escherichia coli, Serratia marcescens, Proteus rettgeri, Enterobacter cloacae and Citrobacter freundii. Thus, this compound may be used for an antibacterial agent in therapeutical purposes.
REFERENCES:
patent: 4033950 (1977-07-01), Cook et al.
patent: 4066762 (1978-01-01), Dunn et al.
patent: 4098888 (1978-07-01), Ochiai
patent: 4202893 (1980-05-01), Heymes et al.
Matsushita Yoshihiro
Morimoto Akira
Ochiai Michihiko
Coughlan, Jr. Paul M.
Takeda Chemical Industries Ltd.
LandOfFree
7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido] cephal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido] cephal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido] cephal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2164713